455 related articles for article (PubMed ID: 17467549)
1. Newborn screening for cystic fibrosis.
Rock MJ
Clin Chest Med; 2007 Jun; 28(2):297-305. PubMed ID: 17467549
[TBL] [Abstract][Full Text] [Related]
2. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
5. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.
Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC
J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
[TBL] [Abstract][Full Text] [Related]
8. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
9. Thirty-years of screening for cystic fibrosis in East Anglia.
Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
11. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
[TBL] [Abstract][Full Text] [Related]
12. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
[TBL] [Abstract][Full Text] [Related]
13. [Newborn screening for cystic fibrosis, a clinical geneticist perspective].
Sanak M
Przegl Lek; 2011; 68(1):14-6. PubMed ID: 21563437
[TBL] [Abstract][Full Text] [Related]
14. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM
Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585
[TBL] [Abstract][Full Text] [Related]
15. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
[TBL] [Abstract][Full Text] [Related]
16. [Implementation of the neonatal cystic fibrosis screening program in Switzerland: beginning January 2011].
Mornand A; Barben J; Hafen G
Rev Med Suisse; 2011 Feb; 7(283):456, 458-60. PubMed ID: 21452515
[TBL] [Abstract][Full Text] [Related]
17. Emerging issues in cystic fibrosis newborn screening.
Castellani C; Massie J
Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
[TBL] [Abstract][Full Text] [Related]
18. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM; Mischler EH
Adv Pediatr; 1992; 39():35-70. PubMed ID: 1442316
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for cystic fibrosis.
Hayes D
South Med J; 2006 Apr; 99(4):403. PubMed ID: 16634253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
